Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors

Gregory J Gores1, Scott H Kaufmann

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA. gores.gregory@mayo.edu

Genes & Development
|February 21, 2012
PubMed